Trust buyers continuing to back Neil Woodford's investment process are eyeing Woodford Patient Capital's share price for an attractive entry point, following its severe decline in the aftermath of the gating of the firm's Equity Income fund.
However, critics have warned the share price may never recover from the fallout and buyers are "better off betting on a horse". Fidelity blocks investors from buying Woodford Income Focus fund Woodford...
Head to remain in Paris to front local credit team
Countdown to 31 October
Two new hires to join firm
Moves from Franklin Templeton